| __timestamp | Cytokinetics, Incorporated | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 44426000 | 179279000 |
| Thursday, January 1, 2015 | 46398000 | 186359000 |
| Friday, January 1, 2016 | 59897000 | 171785000 |
| Sunday, January 1, 2017 | 90296000 | 208136000 |
| Monday, January 1, 2018 | 89135000 | 198405000 |
| Tuesday, January 1, 2019 | 86125000 | 224169000 |
| Wednesday, January 1, 2020 | 96951000 | 245044000 |
| Friday, January 1, 2021 | 159938000 | 252314000 |
| Saturday, January 1, 2022 | 240813000 | 268225000 |
| Sunday, January 1, 2023 | 330123000 | 304629000 |
| Monday, January 1, 2024 | 324203000 |
Cracking the code
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. Over the past decade, Cytokinetics, Incorporated and Taro Pharmaceutical Industries Ltd. have showcased contrasting trends in their cost of revenue. From 2014 to 2023, Cytokinetics saw a staggering increase of over 640% in their cost of revenue, peaking at approximately 330 million in 2023. In contrast, Taro Pharmaceutical's cost of revenue grew by about 70% during the same period, reaching around 305 million in 2023.
This divergence highlights Cytokinetics' aggressive expansion and investment in research, while Taro maintains a more stable cost structure. Notably, the data for 2024 is incomplete, leaving room for speculation on future trends. As these companies navigate the evolving pharmaceutical market, their cost management strategies will be crucial in determining their competitive edge.
Eli Lilly and Company vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Johnson & Johnson and Cytokinetics, Incorporated's Expenses
Analyzing Cost of Revenue: Amgen Inc. and Taro Pharmaceutical Industries Ltd.
Cost of Revenue: Key Insights for Zoetis Inc. and Taro Pharmaceutical Industries Ltd.
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Taro Pharmaceutical Industries Ltd.
Analyzing Cost of Revenue: Catalent, Inc. and Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Cytokinetics, Incorporated and Xenon Pharmaceuticals Inc.'s Expenses
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Mesoblast Limited
Analyzing Cost of Revenue: HUTCHMED (China) Limited and Taro Pharmaceutical Industries Ltd.
Analyzing Cost of Revenue: Mesoblast Limited and Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd. vs Galapagos NV: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Taro Pharmaceutical Industries Ltd. vs Evotec SE